184 related articles for article (PubMed ID: 30724380)
21. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
[TBL] [Abstract][Full Text] [Related]
22. Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells.
Porfire A; Tomuta I; Muntean D; Luca L; Licarete E; Alupei MC; Achim M; Vlase L; Banciu M
J Liposome Res; 2015; 25(4):261-9. PubMed ID: 25487170
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
24. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
25. Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice.
Samra YA; Abdelghany AM; Zaghloul RA
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22869. PubMed ID: 34339076
[TBL] [Abstract][Full Text] [Related]
26. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
27. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.
Monem AS; Elbialy N; Mohamed N
Int J Pharm; 2014 Aug; 470(1-2):1-7. PubMed ID: 24792973
[TBL] [Abstract][Full Text] [Related]
28. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma.
Jameela SR; Latha PG; Subramoniam A; Jayakrishnan A
J Pharm Pharmacol; 1996 Jul; 48(7):685-8. PubMed ID: 8866329
[TBL] [Abstract][Full Text] [Related]
29. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
30. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells.
Alayoubi AY; Anderson JF; Satyanarayanajois SD; Sylvester PW; Nazzal S
Eur J Pharm Sci; 2013 Feb; 48(3):385-92. PubMed ID: 23262057
[TBL] [Abstract][Full Text] [Related]
31. Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation.
Pawar S; Shevalkar G; Vavia P
J Drug Target; 2016 Sep; 24(8):730-43. PubMed ID: 26878084
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
33. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
34. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics.
Deng Y; Zhang H
Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
36. Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice.
Donia TIK; Gerges MN; Mohamed TM
Chem Biol Interact; 2018 Apr; 285():76-84. PubMed ID: 29481770
[TBL] [Abstract][Full Text] [Related]
37. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
[TBL] [Abstract][Full Text] [Related]
38. Influence of anethole treatment on the tumour induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice.
al-Harbi MM; Qureshi S; Raza M; Ahmed MM; Giangreco AB; Shah AH
Eur J Cancer Prev; 1995 Aug; 4(4):307-18. PubMed ID: 7549823
[TBL] [Abstract][Full Text] [Related]
39. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice.
Adwas AA; Elkhoely AA; Kabel AM; Abdel-Rahman MN; Eissa AA
J Infect Chemother; 2016 Jan; 22(1):36-43. PubMed ID: 26603425
[TBL] [Abstract][Full Text] [Related]
40. Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice.
Kandil E; Aziz NA
Tumour Biol; 2016 Feb; 37(2):1825-34. PubMed ID: 26318299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
